首页> Malaria journal> Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

导出 OA

翻译打印收藏纠错

第一作者： Yves Daniel,Compaoré

第一单位： Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Bobo Dioulasso, Burkina Faso. yvesdaniel.co@gmail.com.

作者： Yves Daniel,Compaoré ^[1] ; Issaka,Zongo ^[2] ; Anyirékun F,Somé ^[2] ; Nouhoun,Barry ^[3] ; Frederick,Nikiéma ^[2] ; Talato N,Kaboré ^[4] ; Aminata,Ouattara ^[4] ; Zachari,Kabré ^[2] ; Kadidiatou,Wermi ^[2] ; Moussa,Zongo ^[2] ; Rakiswende S,Yerbanga ^[2] ; Issaka,Sagara ^[5] ; Abdoulaye,Djimdé ^[5] ; Jean Bosco,Ouédraogo ^[2]

作者单位： Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Bobo Dioulasso, Burkina Faso. yvesdaniel.co@gmail.com. ^[1] Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Bobo Dioulasso, Burkina Faso. ^[2] Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso. ^[3] Ministry of Health, Ouagadougou, Burkina Faso. ^[4] Malaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali. ^[5]

关键词 Artemether–lumefantrine Hepatoxicity Hyperbilirubinemia Hy’s law Pyronaridine‐artesunate Repeated treatment Transaminitis Uncomplicated malaria